Metropolitan Life Insurance CO Syros Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

  • $253 Million
  • Q2 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$3.26 - $4.66 $53,512 - $76,493
-16,415 Closed
0 $0
Q3 2021

Jun 21, 2023
BUY
$4.08 - $5.66 $66,973 - $92,908
16,415 New
16,415 $73,000
Q3 2021

Mar 30, 2023
BUY
$4.08 - $5.66 $23,056 - $31,984
5,651 Added 52.5%
16,415 $73,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $5.66 $66,973 - $92,908
16,415 New
16,415 $73,000
Q2 2021

Aug 16, 2021
SELL
$5.01 - $7.48 $55 - $82
-11 Closed
0 $0
Q1 2021

Jun 26, 2023
BUY
$7.19 - $14.95 $77,393 - $160,921
10,764 New
10,764 $80.5 Million
Q1 2021

Mar 30, 2023
SELL
$7.19 - $14.95 $12,517 - $26,027
-1,741 Reduced 13.92%
10,764 $80,000
Q1 2021

May 14, 2021
SELL
$7.19 - $14.95 $89,831 - $186,785
-12,494 Reduced 99.91%
11 $81,000
Q4 2020

Jun 22, 2023
BUY
$6.66 - $14.66 $83,283 - $183,323
12,505 New
12,505 $135,000
Q3 2020

Jun 26, 2023
BUY
$8.69 - $14.47 $108,668 - $180,947
12,505 New
12,505 $110,000
Q2 2020

Jun 26, 2023
BUY
$5.21 - $11.03 $65,151 - $137,930
12,505 New
12,505 $133,000
Q2 2020

Mar 30, 2023
BUY
$5.21 - $11.03 $1,458 - $3,088
280 Added 2.29%
12,505 $133,000
Q2 2020

Aug 14, 2020
BUY
$5.21 - $11.03 $1,458 - $3,088
280 Added 2.29%
12,505 $133,000
Q1 2020

Jul 12, 2023
BUY
$4.46 - $9.2 $54,523 - $112,469
12,225 New
12,225 $72,000
Q1 2020

Mar 30, 2023
SELL
$4.46 - $9.2 $4,745 - $9,788
-1,064 Reduced 8.01%
12,225 $72,000
Q1 2020

May 15, 2020
BUY
$4.46 - $9.2 $54,523 - $112,469
12,225 New
12,225 $72,000
Q4 2019

Feb 14, 2020
SELL
$4.52 - $10.1 $60,066 - $134,218
-13,289 Closed
0 $0
Q3 2019

Jul 12, 2023
BUY
$7.14 - $11.65 $94,883 - $154,816
13,289 New
13,289 $137,000
Q3 2019

Mar 30, 2023
BUY
$7.14 - $11.65 $94,883 - $154,816
13,289 New
13,289 $137,000
Q3 2019

Nov 14, 2019
BUY
$7.14 - $11.65 $94,883 - $154,816
13,289 New
13,289 $138,000
Q2 2019

Jul 12, 2023
BUY
$5.5 - $9.75 $15,939 - $28,255
2,898 New
2,898 $26.8 Million
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $11,249 - $22,986
-2,027 Closed
0 $0
Q3 2018

Jul 13, 2023
BUY
$9.74 - $12.92 $90,163 - $119,600
9,257 New
9,257 $110 Million
Q3 2018

Nov 14, 2018
SELL
$9.74 - $12.92 $70,420 - $93,411
-7,230 Reduced 78.1%
2,027 $24,000
Q2 2018

Aug 15, 2018
BUY
$10.16 - $13.65 $94,051 - $126,358
9,257 New
9,257 $0
Q3 2017

Nov 14, 2017
SELL
$13.52 - $23.75 $131,089 - $230,280
-9,696 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
9,696
9,696 $156,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email